COVID-19
India gives nod to two more anti-COVID-19 vaccines, one drug
New Delhi/IBNS: Strengthening the fight against COVID-19, the Union Health Ministry on Tuesday gave nod to two more anti-COVID-19 vaccines and a drug to battle the deadly virus.
Union Health Minister Mansukh Mandaviya tweeted in the morning to inform that two vaccines, Corbevax and Covovax, and antiviral drug Molnupiravir have been given approvals.
Mandaviya tweeted, "CORBEVAX vaccine is India's 1st indigenously developed RBD protein sub-unit vaccine against #COVID19, Made by Hyderabad-based firm Biological-E."
CORBEVAX vaccine is India's 1st indigenously developed RBD protein sub-unit vaccine against #COVID19, Made by Hyderabad-based firm Biological-E.
— Dr Mansukh Mandaviya (@mansukhmandviya) December 28, 2021
It's a hat-trick! It's now 3rd vaccine developed in India! (2/5)
Covovax, a nanoparticle vaccine, will be manufactured by Pune-based Serum Institute of India (SII).
With the two new vaccines getting the nod, India now has eight in total to fight against the contagion.
Apart from the two new, India has Covishield, Covaxin, ZyCoV-D, Sputnik V, Moderna and Johnson and Johnson.
The emergency approvals came in the backdrop of the rising cases of COVID-19 variant 'Omicron' in India, the health infrastructure of which was crippled during the second wave of the virus.
Several Indian states have already started imposing restrictions to curb the spread of the virus with the emergence of the new variant.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
